Pharmacological Modeling of New Form of Anti-tumorigenic Medicines in Chemotherapy
DOI:
https://doi.org/10.37591/tdd.v6i1.452Abstract
The existing methods of chemotherapeutic treatment do not permit to calculate the precise dose of medicine and the time of its action on the tumor that leads to unpredictability of result, and, therefore, to the ineffectiveness of the use of treatment itself. Furthermore, the damage of normal cells on chemotherapy becomes the reason for a whole series of complications, connected with side-effects action of chemotherapy. The paper presents the pharmacological modeling of processing of the fundamentally new form of antitumorigenic medicines with the calculated precise dose of action of cytostatic on the tumor cells at the moment of their mitosis (indirect division of cells). The new form of antitumorigenic medicines is a support material with equally distributed spherical drops of cytostatic. The support material, thus, is a solid at room temperature and is melted at human body temperature, during its implanting into the body parts of patient, which supply the tumor by the blood, will dosed act directly on tumor cells at the moment of their mitosis using the equally distributed drops of cytostatic. Any treating chemotherapist can calculate the impact dose and time of action of cytostatic that fall accurately on the mitosis of cancerous cells, if he knows the volume of each drop and their total quantity in the support material, and also the time of melting of the support material. The calculated dose of cytostatic in the support material is reached by injection of the assigned by chemotherapist volume of the cytostatic in the form of spherical drops through the specific gap inside the camera for the molten support material byway of bubbling in the weightlessness conditions.
Keywords: Pharmacological modeling antitumorigenic medicines, tumor cells, bubbling, weightlessness conditions
Cite this Article
M. Shoikhedbrod. Pharmacological Modeling of New Form of Antitumorigenic Medicines in Chemotherapy. Trends in Drug Delivery. 2019; 6(1): 31–36p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |
